Central neurocytoma: a multi-disciplinary review.

Area of Science:

• Neuro-oncology
• Neurosurgery
• Neuropathology

Background:

• Benign central neurocytoma (CN) is a rare neuronal tumor of the central nervous system.
• Over 300 articles exist, primarily case reports, highlighting a need for comprehensive review.
• CN recurrence after surgery is more common than previously assumed, necessitating advanced management strategies.

Purpose of the Study:

• To provide a comprehensive review of benign central neurocytoma (CN).
• To emphasize the necessity of a multi-modality team approach for optimal CN management.
• To highlight the latest developments in CN histology, molecular biology, and adjuvant treatments.

Main Methods:

• Literature review of over 300 published articles on central neurocytoma.
• Synthesis of information from various neurosciences sub-specialties.
• Emphasis on recent advancements in pathology, molecular biology, and treatment.

Main Results:

• Central neurocytoma (CN) recurrence post-surgery is a significant concern.
• A multidisciplinary team approach is crucial for effective CN management.
• Latest research in histology, molecular biology, and adjuvant therapies is vital for recurrent or residual disease.

Conclusions:

• Central neurocytoma (CN) management requires a collaborative, multidisciplinary approach.
• Continuous updates in understanding CN's molecular biology and histology are essential.
• Adjuvant treatment modalities are critical for managing recurrent or residual CN.